EPO and Stroke: EPO resistance is a potential risk factor for mortality, cardiovascular disease, and stroke, which are associated with the high-dose use of EPO-stimulating agents and inability to achieve a target hemoglobin level (Kilpatrick et al. 2008; Szczech et al. 2008).